Atlas Trials

A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver

Clinical trial NCT03357380 · COMPLETED

Trial details

NCT number
NCT03357380
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatobiliary DisordersNon-alcoholic Fatty Liver Disease
Start date
2017-11-28
Primary completion
2020-03-20
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.